We are live on ! Find out more

29 hedge funds and large institutions have $873K invested in PAVmed in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

34% more capital invested

Capital invested by funds: $654K → $873K (+$220K)

26% more funds holding

Funds holding: 2329 (+6)

0.07% less ownership

Funds ownership: 0.31%0.25% (-0.07%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
29
Holders Change
+6
Holders Change %
+26.09%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
3
Reduced
4
Closed
3
Calls
$42K
Puts
Net Calls
+$42K
Net Calls Change
+$42K

PAVM Hedge Fund Activity: Q1 2025 in Review

29 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2025, worth a combined $873K — up 34% from $654K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PAVM positions and 3 closed out — a net gain of 6 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $45K. The largest seller was UBS Group, cutting an estimated $8.02K.

  • 29 institutional investors held PAVmed (PAVM) as of Q1 2025, up from 23 in Q4 2024.
  • Funds reported $873K of PAVmed stock for Q1 2025, up 34% quarter-over-quarter.
  • 9 funds opened new PAVmed positions in Q1 2025 and 3 closed out, a net change of +6 holders.
  • The largest PAVmed buyer in Q1 2025 was CAPTRUST Financial Advisors, an estimated $45K added.
  • The largest PAVmed seller in Q1 2025 was UBS Group, an estimated $8.02K sold.

Based on aggregated 13F filings for Q1 2025.